Healx Appoints Christopher Moertel as Global Head of Clinical Development

Cambridge, UK, 6 May 2025 – Healx, a leader in AI-driven drug discovery for rare diseases, is pleased to announce the appointment of Christopher Moertel, M.D., as its new Global Head of Clinical Development. Dr. Moertel, a highly respected expert in the field, brings a wealth of experience in clinical research and drug development, particularly … Continued The post Healx Appoints Christopher Moertel as Global Head of Clinical Development appeared first on Healx .